Hydantoin compound and uses of hydantoin compound as beta-secretase inhibitor
The present invention belongs to the field of pharmaceutical chemistry industry, and relates to a hydantoin compound and uses of the hydantoin compound as a beta-secretase inhibitor, particularly to a compound represented by a formula I or a pharmaceutically acceptable salt, a solvate or a hydrate t...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention belongs to the field of pharmaceutical chemistry industry, and relates to a hydantoin compound and uses of the hydantoin compound as a beta-secretase inhibitor, particularly to a compound represented by a formula I or a pharmaceutically acceptable salt, a solvate or a hydrate thereof. According to the present invention, the compound represented by the formula I can be used as the beta-secretase inhibitor, and can be used for preparing drugs for treatment and/or prevention of diseases or disorders associated with beta-amyloid polypeptide aggregation or precipitation. The formula I, G1 and G2 are as defined in the specification.
本发明属于医药化工领域,涉及乙内酰脲类化合物及其作为β-分泌酶抑制剂的用途。具体地,本发明涉及式I化合物或其可药用盐、溶剂合物或水合物。本发明式I化合物可作为β-分泌酶抑制剂使用,能够用于制备用于治疗和/或预防与β-淀粉样多肽聚集或沉淀有关的疾病或病症的药物。其中G、G如本文中所定义。 |
---|